Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: A systematic review of current evidence
Authors:
- Laura FadenLFLaura Faden
- Catherine Vialle-ValentinCVCatherine Vialle-Valentin
- Dennis Ross-DegnanDRDennis Ross-Degnan
- Anita WagnerAWAnita Wagner
- 1 May 2011
- journal article
- review article
- Published by Elsevier in Health Policy
- Vol. 100 (2-3) , 134-143
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health SurveyHealth Policy, 2011
- Non-evidence-based policy: How effective is China's new cooperative medical scheme in reducing medical impoverishment?Social Science & Medicine, 2009
- Universal coverage of health services: tailoring its implementationBulletin of the World Health Organization, 2008
- Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature – 2001–2007BMC Health Services Research, 2008
- Pharmaceutical policies: effects of financial incentives for prescribers2007
- Prescription Drug Cost SharingJAMA, 2007
- Health insurance benefit packages prioritized by low-income clients in India: Three criteria to estimate effectiveness of choiceSocial Science & Medicine, 2007
- 25 years of the WHO essential medicines lists: progress and challengesThe Lancet, 2003
- Ensuring access to essential medicines in the developing countries: a framework for actionClinical Pharmacology & Therapeutics, 2003
- The Effect of Explicit Financial Incentives on Physician BehaviorArchives of internal medicine (1960), 2001